Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels-Reference-Cited by-同舟云学术

Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels

Published:2011-02-15 Issue:6 Volume:129 Page:675-685
ISSN:0340-6717
Container-title:Human Genetics
language:en
Short-container-title:Hum Genet

Author:

Parikh Hemang,Wang Zhaoming,Pettigrew Kerry A.,Jia Jinping,Daugherty Sarah,Yeager Meredith,Jacobs Kevin B.,Hutchinson Amy,Burdett Laura,Cullen Michael,Qi Liqun,Boland Joseph,Collins Irene,Albert Thomas J.,Vatten Lars J.,Hveem Kristian,Njølstad Inger,Cancel-Tassin Geraldine,Cussenot Olivier,Valeri Antoine,Virtamo Jarmo,Thun Michael J.,Feigelson Heather Spencer,Diver W. Ryan,Chatterjee Nilanjan,Thomas Gilles,Albanes Demetrius,Chanock Stephen J.,Hunter David J.,Hoover Robert,Hayes Richard B.,Berndt Sonja I.,Sampson Joshua,Amundadottir Laufey

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.springerlink.com/index/pdf/10.1007/s00439-011-0953-5

Reference33 articles.

1. Ahn J, Berndt SI, Wacholder S, Kraft P, Kibel AS, Yeager M, Albanes D, Giovannucci E, Stampfer MJ, Virtamo J, Thun MJ, Feigelson HS, Cancel-Tassin G, Cussenot O, Thomas G, Hunter DJ, Fraumeni JF Jr, Hoover RN, Chanock SJ, Hayes RB (2008) Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 40:1032–1034 author reply 1035–1036

2. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Bonnen PE, de Bakker PI, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia X, Palotie A, Parkin M, Whittaker P, Chang K, Hawes A, Lewis LR, Ren Y, Wheeler D, Muzny DM, Barnes C, Darvishi K, Hurles M, Korn JM, Kristiansson K, Lee C, McCarrol SA, Nemesh J, Keinan A, Montgomery SB, Pollack S, Price AL, Soranzo N, Gonzaga-Jauregui C, Anttila V, Brodeur W, Daly MJ, Leslie S, McVean G, Moutsianas L, Nguyen H, Zhang Q, Ghori MJ, McGinnis R, McLaren W, Takeuchi F, Grossman SR, Shlyakhter I, Hostetter EB, Sabeti PC, Adebamowo CA, Foster MW, Gordon DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C, Brooks LD, McEwen JE (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467:52–58

3. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310–1319

4. Binkley J, Karra K, Kirby A, Hosobuchi M, Stone EA, Sidow A (2010) ProPhylER: a curated online resource for protein function and structure based on evolutionary constraint analyses. Genome Res 20:142–154

5. Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R (2009) Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat 30:1237–1244

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer;Journal of Urology;2024-06

2. Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies;Current Opinion in Urology;2023-08-13

3. Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies;Biomedicines;2022-10-28

4. Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study;Cancers;2022-04-15

5. Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies;Prostate Cancer and Prostatic Diseases;2022-03-28